scholarly article | Q13442814 |
P50 | author | Abdullah Hamad | Q59832113 |
Tung O. Chan | Q41149903 | ||
P2093 | author name string | Xue Li | |
Jianliang Song | |||
Joseph Y Cheung | |||
Xue-Qian Zhang | |||
Jin Zhang | |||
Arthur M Feldman | |||
Hajime Funakoshi | |||
Jufang Wang | |||
Valerie Myers | |||
Glenn L Radice | |||
David Swope | |||
Jifen Li | |||
John Farber | |||
Ashley Madonick | |||
P2860 | cites work | Doxorubicin directly binds to the cardiac-type ryanodine receptor | Q44084096 |
Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism | Q44175825 | ||
Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function | Q44997554 | ||
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy | Q45161679 | ||
Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy | Q45175898 | ||
Adenosine A2A receptor facilitates calcium-dependent protein secretion through the activation of protein kinase A and phosphatidylinositol-3 kinase in PC12 cells | Q45234795 | ||
Doxorubicin-induced second degree and complete atrioventricular block | Q46476597 | ||
Transcriptional analysis of doxorubicin-induced cardiotoxicity | Q46769518 | ||
Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence | Q47322889 | ||
Cardiac ultrastructural changes induced by daunorubicin therapy. | Q53731811 | ||
Effects of first-dose doxorubicin on cardiac rhythm as evaluated by continuous 24-hour monitoring. | Q53840944 | ||
Cardiac-Specific Loss of N-Cadherin Leads to Alteration in Connexins With Conduction Slowing and Arrhythmogenesis | Q57396516 | ||
Regulated Overexpression of the A 1 -Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function | Q62583213 | ||
Heterogeneous Expression of Gap Junction Channels in the Heart Leads to Conduction Defects and Ventricular Dysfunction | Q63425482 | ||
Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response | Q67590955 | ||
Electrode positioning for reliable telemetry ECG recordings during social stress in unrestrained rats | Q71840321 | ||
Direct effects of adriamycin on the rat heart sarcolemma | Q72574539 | ||
Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia | Q73071883 | ||
Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure | Q73204498 | ||
Conditional gene targeting of connexin43: exploring the consequences of gap junction remodeling in the heart | Q74299117 | ||
Doxorubicin, to treat cancers or to cause cardiac injury, that is the question | Q77194640 | ||
Doxorubicin-induced cardiomyopathy | Q77323607 | ||
Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy | Q80522312 | ||
The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart | Q24540404 | ||
The A(2A)-adenosine receptor: a GPCR with unique features? | Q24653743 | ||
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 | ||
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer | Q27824847 | ||
Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart | Q28214586 | ||
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction | Q28261916 | ||
Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo | Q28337579 | ||
Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity | Q28379102 | ||
Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43 | Q28506915 | ||
Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes | Q28565992 | ||
Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange | Q30444270 | ||
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion | Q30477474 | ||
Optimal rotational interval for 3-dimensional echocardiography data acquisition for rapid and accurate measurement of left ventricular function | Q30607015 | ||
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro | Q33614685 | ||
Broad-spectrum cardioprotection with adenosine | Q33786692 | ||
Adenosine and cardioprotection during ischaemia and reperfusion--an overview | Q34058386 | ||
Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia | Q34205638 | ||
Acute adenosinergic cardioprotection in ischemic-reperfused hearts | Q35560907 | ||
Connexin phosphorylation as a regulatory event linked to gap junction channel assembly | Q36162583 | ||
SERCA2a in heart failure: role and therapeutic prospects | Q36476041 | ||
N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility. | Q36561910 | ||
Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. | Q37282970 | ||
Subcellular effects of adriamycin in the heart: a concise review | Q39686848 | ||
Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor | Q39828113 | ||
Inhibition of sodium-potassium-activated adenosine 5'-triphosphatase and ion transport by adriamycin | Q40203178 | ||
Anthracycline-associated cardiac and renal damage in rabbits. Evidence for mediation by vasoactive substances | Q41540340 | ||
Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy | Q42226173 | ||
HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia | Q42512319 | ||
Molecular biology of doxorubicin-induced cardiomyopathy | Q42583605 | ||
Overexpression of Na+/Ca2+ exchanger alters contractility and SR Ca2+ content in adult rat myocytes | Q43773147 | ||
P433 | issue | 6 | |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | H1738-47 | |
P577 | publication date | 2010-04-02 | |
P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
P1476 | title | Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicity | |
P478 | volume | 298 |
Q37891696 | Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man. |
Q30537619 | Alterations in cardiac DNA methylation in human dilated cardiomyopathy |
Q34335762 | Cardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overload |
Q35178670 | Ca²⁺ entry via Trpm2 is essential for cardiac myocyte bioenergetics maintenance |
Q37700637 | Identification of candidate long noncoding RNAs associated with left ventricular hypertrophy |
Q35543463 | Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage density |
Q49631774 | Phenotyping of Mice with Heart Specific Overexpression of A2A-Adenosine Receptors: Evidence for Cardioprotective Effects of A2A-Adenosine Receptors |
Search more.